Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY 18.49
(-0.59%)
CNY 18.49
(-0.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 13.09 Billion CNY | 6.98% |
| 2022 | 12.24 Billion CNY | 21.58% |
| 2021 | 10.06 Billion CNY | 7.53% |
| 2020 | 9.36 Billion CNY | 28.25% |
| 2019 | 7.3 Billion CNY | 27.51% |
| 2018 | 5.72 Billion CNY | 43.66% |
| 2017 | 3.98 Billion CNY | 31.05% |
| 2016 | 3.04 Billion CNY | 3.29% |
| 2015 | 2.94 Billion CNY | 14.94% |
| 2014 | 2.56 Billion CNY | 16.61% |
| 2013 | 2.19 Billion CNY | 33.08% |
| 2012 | 1.65 Billion CNY | 27.04% |
| 2011 | 1.29 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 13.26 Billion CNY | 1.32% |
| 2024 Q2 | 13.85 Billion CNY | 4.39% |
| 2024 Q3 | 13.76 Billion CNY | -0.62% |
| 2023 FY | 13.09 Billion CNY | 6.98% |
| 2023 Q1 | 12.28 Billion CNY | 0.33% |
| 2023 Q3 | 13.85 Billion CNY | -2.89% |
| 2023 Q4 | 13.09 Billion CNY | -5.49% |
| 2023 Q2 | 14.26 Billion CNY | 16.17% |
| 2022 Q4 | 12.24 Billion CNY | -5.87% |
| 2022 Q2 | 12.05 Billion CNY | 10.4% |
| 2022 Q1 | 10.92 Billion CNY | 8.48% |
| 2022 Q3 | 13 Billion CNY | 7.86% |
| 2022 FY | 12.24 Billion CNY | 21.58% |
| 2021 FY | 10.06 Billion CNY | 7.53% |
| 2021 Q1 | 9.46 Billion CNY | 1.05% |
| 2021 Q2 | 10.74 Billion CNY | 13.57% |
| 2021 Q3 | 10.89 Billion CNY | 1.39% |
| 2021 Q4 | 10.06 Billion CNY | -7.59% |
| 2020 Q4 | 9.36 Billion CNY | 4.42% |
| 2020 Q1 | 8.35 Billion CNY | 14.38% |
| 2020 FY | 9.36 Billion CNY | 28.25% |
| 2020 Q2 | 8.16 Billion CNY | -2.26% |
| 2020 Q3 | 8.96 Billion CNY | 9.86% |
| 2019 Q2 | 7.81 Billion CNY | 11.28% |
| 2019 FY | 7.3 Billion CNY | 27.51% |
| 2019 Q4 | 7.3 Billion CNY | -11.73% |
| 2019 Q3 | 8.27 Billion CNY | 5.86% |
| 2019 Q1 | 7.02 Billion CNY | 22.62% |
| 2018 Q1 | 4.58 Billion CNY | 15.09% |
| 2018 Q4 | 5.72 Billion CNY | 9.57% |
| 2018 FY | 5.72 Billion CNY | 43.66% |
| 2018 Q3 | 5.22 Billion CNY | 9.5% |
| 2018 Q2 | 4.77 Billion CNY | 4.04% |
| 2017 Q4 | 3.98 Billion CNY | 4.61% |
| 2017 FY | 3.98 Billion CNY | 31.05% |
| 2017 Q3 | 3.81 Billion CNY | 14.25% |
| 2017 Q2 | 3.33 Billion CNY | 3.82% |
| 2017 Q1 | 3.21 Billion CNY | 5.62% |
| 2016 FY | 3.04 Billion CNY | 3.29% |
| 2016 Q4 | 3.04 Billion CNY | 17.56% |
| 2016 Q2 | 2.6 Billion CNY | -5.63% |
| 2016 Q1 | 2.75 Billion CNY | -6.28% |
| 2016 Q3 | 2.58 Billion CNY | -0.67% |
| 2015 Q2 | 2.67 Billion CNY | 9.63% |
| 2015 Q4 | 2.94 Billion CNY | 3.24% |
| 2015 Q3 | 2.85 Billion CNY | 6.71% |
| 2015 Q1 | 2.43 Billion CNY | -4.83% |
| 2015 FY | 2.94 Billion CNY | 14.94% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q3 | 2.72 Billion CNY | 7.78% |
| 2014 Q4 | 2.56 Billion CNY | -6.13% |
| 2014 FY | 2.56 Billion CNY | 16.61% |
| 2014 Q2 | 2.53 Billion CNY | 0.0% |
| 2013 FY | 2.19 Billion CNY | 33.08% |
| 2013 Q4 | 2.19 Billion CNY | 0.0% |
| 2012 FY | 1.65 Billion CNY | 27.04% |
| 2011 FY | 1.29 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| China Meheco Group Co., Ltd. | 21.47 Billion CNY | 39.015% |
| Liaoning Cheng Da Co., Ltd. | 15.16 Billion CNY | 13.641% |
| Shanghai Pharmaceuticals Holding Co., Ltd | 131.08 Billion CNY | 90.009% |